1. Home
  2. DX vs ICUI Comparison

DX vs ICUI Comparison

Compare DX & ICUI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Dynex Capital Inc.

DX

Dynex Capital Inc.

HOLD

Current Price

$12.71

Market Cap

3.0B

Sector

Real Estate

ML Signal

HOLD

Logo ICU Medical Inc.

ICUI

ICU Medical Inc.

HOLD

Current Price

$168.51

Market Cap

3.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DX
ICUI
Founded
1987
1984
Country
United States
United States
Employees
28
N/A
Industry
Real Estate Investment Trusts
Medical/Dental Instruments
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.0B
3.6B
IPO Year
N/A
1995

Fundamental Metrics

Financial Performance
Metric
DX
ICUI
Price
$12.71
$168.51
Analyst Decision
Buy
Strong Buy
Analyst Count
3
3
Target Price
$14.75
$169.00
AVG Volume (30 Days)
5.8M
252.3K
Earning Date
04-20-2026
05-07-2026
Dividend Yield
15.11%
N/A
EPS Growth
N/A
100.62
EPS
N/A
1.20
Revenue
N/A
$2,231,262,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$4.46
P/E Ratio
$5.66
$140.00
Revenue Growth
N/A
N/A
52 Week Low
$11.83
$107.02
52 Week High
$14.93
$170.81

Technical Indicators

Market Signals
Indicator
DX
ICUI
Relative Strength Index (RSI) 41.02 66.56
Support Level $12.14 $139.88
Resistance Level $13.24 N/A
Average True Range (ATR) 0.26 4.92
MACD -0.04 0.49
Stochastic Oscillator 10.88 85.51

Price Performance

Historical Comparison
DX
ICUI

About DX Dynex Capital Inc.

Dynex Capital Inc is a real estate investment trust (REIT) focused on delivering dividends supported by long term returns from investments in mortgage assets backed by U.S. housing and commercial real estate. The Company is internally managed and mainly invests in residential and commercial mortgage-backed securities (RMBS and CMBS), which are Agency securities guaranteed by U.S. government-sponsored enterprises (GSEs). It manages interest rate, prepayment, spread, liquidity, and counterparty risks and operates through one reportable segment investing in MBS funded with repurchase agreements and equity.

About ICUI ICU Medical Inc.

ICU Medical is a California-based pure-play infusion therapy company that provides consumables, systems, and services for virtually every component of the IV continuum of care. ICU has become one of the largest players in its industry following its acquisition of Hospira Infusion Systems from Pfizer in 2017 and Smiths Medical from Smiths Group in 2022. It holds top-tier positions across its three reporting segments: consumables (50% of consolidated revenue), infusion systems (30%), and vital care (20%). The combined entity remains primarily US-focused, generating over 60% of its sales domestically.

Share on Social Networks: